Literature DB >> 295516

The pharmacokinetic profile of pirenzepine.

R Hammer, F W Koss.   

Abstract

This paper gives a brief review of the pharmacokinetic studies performed on pirenzepine (L S 519 Cl2, Gastrozepin hitherto. Particular attention will be paid thereby to the clinical significance of the pharmacokinetic parameters.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 295516

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN： 0085-5928


  11 in total

1.  Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man.

Authors:  V Garrigues; J Ponce; C Cano; R Sopena; M Hoyos; A Del Val; J Berenguer
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats.

Authors:  P Worms; C Gueudet; A Pério; P Soubrié
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine.

Authors:  W Londong; V Londong; C Federle; P Tanswell; U Voderholzer
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy.

Authors:  Nigel A Calcutt; Darrell R Smith; Katie Frizzi; Mohammad Golam Sabbir; Subir K Roy Chowdhury; Teresa Mixcoatl-Zecuatl; Ali Saleh; Nabeel Muttalib; Randy Van der Ploeg; Joseline Ochoa; Allison Gopaul; Lori Tessler; Jürgen Wess; Corinne G Jolivalt; Paul Fernyhough
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

Review 6.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

7.  Muscarinic receptor blockade by pirenzepine: effect on prolactin secretion in man.

Authors:  A Masala; S Alagna; L Devilla; P P Rovasio; S Rassa; R Faedda; A Satta
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

8.  Identification of muscarinic receptor subtype mediating colonic response to eating.

Authors:  F Narducci; G Bassotti; S Daniotti; P Del Soldato; M A Pelli; A Morelli
Journal:  Dig Dis Sci       Date:  1985-02       Impact factor: 3.199

9.  Investigation into atropine-induced antinociception.

Authors:  C Ghelardini; P Malmberg-Aiello; A Giotti; M Malcangio; A Bartolini
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

10.  Comparison of central gastric antisecretory effects of desmethylimipramine, doxepin and pirenzepine in rats.

Authors:  R G Pendleton; M Williams; C Chung; P Cook; E Risley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.